Endothelial cell clonal expansion in the development of cerebral cavernous malformations
Matteo Malinverno (),
Claudio Maderna,
Abdallah Abu Taha,
Monica Corada,
Fabrizio Orsenigo,
Mariaelena Valentino,
Federica Pisati,
Carmela Fusco,
Paolo Graziano,
Monica Giannotta,
Qing Cissy Yu,
Yi Arial Zeng,
Maria Grazia Lampugnani,
Peetra U. Magnusson and
Elisabetta Dejana ()
Additional contact information
Matteo Malinverno: The FIRC Institute of Molecular Oncology Foundation
Claudio Maderna: The FIRC Institute of Molecular Oncology Foundation
Abdallah Abu Taha: Uppsala University
Monica Corada: The FIRC Institute of Molecular Oncology Foundation
Fabrizio Orsenigo: The FIRC Institute of Molecular Oncology Foundation
Mariaelena Valentino: The FIRC Institute of Molecular Oncology Foundation
Federica Pisati: The FIRC Institute of Molecular Oncology Foundation
Carmela Fusco: Fondazione IRCCS-Casa Sollievo della Sofferenza
Paolo Graziano: Fondazione IRCCS-Casa Sollievo della Sofferenza
Monica Giannotta: The FIRC Institute of Molecular Oncology Foundation
Qing Cissy Yu: Chinese Academy of Sciences
Yi Arial Zeng: Chinese Academy of Sciences
Maria Grazia Lampugnani: The FIRC Institute of Molecular Oncology Foundation
Peetra U. Magnusson: Uppsala University
Elisabetta Dejana: The FIRC Institute of Molecular Oncology Foundation
Nature Communications, 2019, vol. 10, issue 1, 1-16
Abstract:
Abstract Cerebral cavernous malformation (CCM) is a neurovascular familial or sporadic disease that is characterised by capillary-venous cavernomas, and is due to loss-of-function mutations to any one of three CCM genes. Familial CCM follows a two-hit mechanism similar to that of tumour suppressor genes, while in sporadic cavernomas only a small fraction of endothelial cells shows mutated CCM genes. We reported that in mouse models and in human patients, endothelial cells lining the lesions have different features from the surrounding endothelium, as they express mesenchymal/stem-cell markers. Here we show that cavernomas originate from clonal expansion of few Ccm3-null endothelial cells that express mesenchymal/stem-cell markers. These cells then attract surrounding wild-type endothelial cells, inducing them to express mesenchymal/stem-cell markers and to contribute to cavernoma growth. These characteristics of Ccm3-null cells are reminiscent of the tumour-initiating cells that are responsible for tumour growth. Our data support the concept that CCM has benign tumour characteristics.
Date: 2019
References: Add references at CitEc
Citations: View citations in EconPapers (2)
Downloads: (external link)
https://www.nature.com/articles/s41467-019-10707-x Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10707-x
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-019-10707-x
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().